Status:
COMPLETED
Evaluation of Calcinosis in Systemic Sclerosis
Lead Sponsor:
University Hospital, Lille
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Systemic sclerosis is a rare pathology characterized by fibrosis and vascular lesion with skin, pulmonary, digestive and cardiac localisation. Calcinosis cutis is commonly described, but its prevalenc...
Eligibility Criteria
Inclusion
- Systemic sclerosis presenting ACR-EULAR 2013 criteria
- Given their consent
- Titulary of health insurance
Exclusion
- Dermatomyositis overlap
- Pregnant or breastfeeding women
- Imprisoned person
- Refuse of consent
Key Trial Info
Start Date :
November 30 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 2 2021
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT03340194
Start Date
November 30 2017
End Date
April 2 2021
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Claude Huriez, CHU
Lille, France